journal article·2023-11-03

Aptamer and DNAzyme-Functionalized Cu-MOF Hybrid Nanozymes for the Monitoring and Management of Bacteria-Infected Wounds

Fayin Mo, Sheng Zhong, Tianhui You, Jing Lu, Duanping Sun

Publisher page

Abstract

Metal–organic frameworks (MOFs) with peroxidase (POD)-like activity have great potential for combating drug-resistant bacterial infections. However, the use of POD-like activities is severely limited by low oxygen levels and high levels of glutathione (GSH) within the microenvironment of bacterial infection. Herein, G-quadruplex/hemin DNAzyme-aptamer probes and tannic acid-chelated Au nanoparticle (Au-TA)-decorated Cu-based MOF nanosheets (termed GATC) with triple-enzyme activities were developed for visual detection and efficient antibacterial therapy. First, the monometallic MOFs (Cu-ZIF) showed the best catalytic and loading capacity performance compared with the bimetallic MOFs (CoCu-ZIF and ZnCu-ZIF). Then, Cu-MOFs, Au-TA, and DNAzyme improve the POD-like activity to generate more hydroxyl radicals (•OH) to kill bacteria. GATC can bind to bacteria through aptamer recognition, increasing the bacterial surface contact area for efficient antibacterial activity. GATC can decompose H 2 O 2 into O 2 to alleviate hypoxia and improve the microenvironment due to its catalase (CAT)-like activity. In addition, GATC exhibited GSH peroxidase-like activity, which can avoid the loss of •OH and result in bacterial death more easily. Compared with previous studies, GATC exhibited extraordinary bactericidal ability at an extremely low dosage of 3 μg/mL against methicillin-resistant Staphylococcus aureus ( MRSA ). Notably, the GATC-catalyzed chromogenic reaction could accurately monitor the MRSA infection treatment process. Overall, this work could establish a therapeutic platform for the monitoring and management of bacteria-infected wounds.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Drug Research and Development, Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, China

Key Specialty of Clinical Pharmacy, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510699, Guangdong, China

National and Local United Engineering Lab of Druggability and New Drugs Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, Guangdong, China

Funding

National Key Clinical Specialty Discipline Construction Program of China · Science Fund for Distinguished Young Scholars of Guangdong Province · Guangzhou Municipal Science and Technology Bureau · Department of Education of Guangdong Province · National Natural Science Foundation of China · Guangdong Province · National Key Clinical Specialty Construction Project

References (68)

Show source-provided references
1. 10.1038/nchembio.2007.2410.1038/nchembio.2007.24 ↗
2. 10.1038/s41586-018-0278-910.1038/s41586-018-0278-9 ↗
3. 10.1016/j.addr.2017.08.00110.1016/j.addr.2017.08.001 ↗
4. 10.1016/j.jiec.2018.09.04810.1016/j.jiec.2018.09.048 ↗
5. 10.1021/acs.accounts.8b0001110.1021/acs.accounts.8b00011 ↗
6. 10.1002/adma.20200542310.1002/adma.202005423 ↗
7. 10.1002/anie.20190828910.1002/anie.201908289 ↗
8. 10.1002/smll.20190593810.1002/smll.201905938 ↗
9. 10.1016/j.jpha.2020.12.00310.1016/j.jpha.2020.12.003 ↗
10. 10.1126/sciadv.aaz476710.1126/sciadv.aaz4767 ↗
11. 10.1016/j.eng.2020.08.02210.1016/j.eng.2020.08.022 ↗
12. 10.1021/acsami.9b1758110.1021/acsami.9b17581 ↗
13. 10.1021/jacs.1c0787510.1021/jacs.1c07875 ↗
14. 10.1021/acsami.0c0166610.1021/acsami.0c01666 ↗
15. 10.1002/adma.20190410610.1002/adma.201904106 ↗
16. 10.1039/C8CS00457A10.1039/C8CS00457A ↗
17. 10.1016/j.cej.2021.12943110.1016/j.cej.2021.129431 ↗
18. 10.1016/j.jpha.2020.09.00210.1016/j.jpha.2020.09.002 ↗
19. 10.1002/smll.20200055310.1002/smll.202000553 ↗
20. 10.1021/acsami.1c1060010.1021/acsami.1c10600 ↗
21. 10.1021/acsnano.1c0089410.1021/acsnano.1c00894 ↗
22. 10.1021/acsami.0c1098110.1021/acsami.0c10981 ↗
23. 10.1016/j.jcis.2022.08.07310.1016/j.jcis.2022.08.073 ↗
24. 10.1016/j.cis.2022.10268610.1016/j.cis.2022.102686 ↗
25. 10.1021/ic990334t10.1021/ic990334t ↗
26. 10.1016/j.biomaterials.2021.12107110.1016/j.biomaterials.2021.121071 ↗
27. 10.1016/j.nantod.2020.10094610.1016/j.nantod.2020.100946 ↗
28. 10.1039/D0TB02360D10.1039/D0TB02360D ↗
29. 10.1002/smll.20200109910.1002/smll.202001099 ↗
30. 10.1021/acsami.1c0575110.1021/acsami.1c05751 ↗
31. 10.1002/adhm.20190135810.1002/adhm.201901358 ↗
32. 10.1021/ja800564410.1021/ja8005644 ↗
33. 10.1002/anie.20210771210.1002/anie.202107712 ↗
34. 10.1021/acsami.5b1016510.1021/acsami.5b10165 ↗
35. 10.1021/acs.jpclett.0c0368810.1021/acs.jpclett.0c03688 ↗
36. 10.1021/acs.analchem.0c0274410.1021/acs.analchem.0c02744 ↗
37. 10.1016/j.trac.2019.11578610.1016/j.trac.2019.115786 ↗
38. 10.1007/s00216-021-03524-z10.1007/s00216-021-03524-z ↗
39. 10.1016/j.ccr.2021.21426410.1016/j.ccr.2021.214264 ↗
40. 10.1021/acsami.0c1126910.1021/acsami.0c11269 ↗
41. 10.1039/D0RA10423J10.1039/D0RA10423J ↗
42. 10.1073/pnas.060243910310.1073/pnas.0602439103 ↗
43. 10.1021/acs.analchem.2c0313810.1021/acs.analchem.2c03138 ↗
44. 10.1039/D2TA05833B10.1039/D2TA05833B ↗
45. 10.1016/j.ccr.2021.21432710.1016/j.ccr.2021.214327 ↗
46. 10.1002/anie.20100755710.1002/anie.201007557 ↗
47. 10.1016/j.jhazmat.2015.07.07910.1016/j.jhazmat.2015.07.079 ↗
48. 10.1016/j.bioactmat.2021.01.03310.1016/j.bioactmat.2021.01.033 ↗
49. 10.1021/am500266310.1021/am5002663 ↗
50. 10.1021/acs.chemmater.7b0334910.1021/acs.chemmater.7b03349 ↗
51. 10.1016/j.apcatb.2021.12055110.1016/j.apcatb.2021.120551 ↗
52. 10.1016/j.bioactmat.2021.07.02310.1016/j.bioactmat.2021.07.023 ↗
53. 10.1021/acs.analchem.2c0060010.1021/acs.analchem.2c00600 ↗
54. 10.1186/s12951-022-01617-010.1186/s12951-022-01617-0 ↗
55. 10.1093/nar/gkad03110.1093/nar/gkad031 ↗
56. 10.1002/adma.20200689210.1002/adma.202006892 ↗
57. 10.1021/jacs.7b1111410.1021/jacs.7b11114 ↗
58. 10.1074/jbc.274.8.487610.1074/jbc.274.8.4876 ↗
59. 10.1039/D2CS00236A10.1039/D2CS00236A ↗
60. 10.1111/iwj.1255710.1111/iwj.12557 ↗
61. 10.1016/j.biomaterials.2020.12028610.1016/j.biomaterials.2020.120286 ↗
62. 10.3390/molecules2701005010.3390/molecules27010050 ↗
63. 10.1021/acsami.1c2423110.1021/acsami.1c24231 ↗
64. 10.1016/j.jinorgbio.2015.08.00510.1016/j.jinorgbio.2015.08.005 ↗
65. 10.1021/acsami.8b1287310.1021/acsami.8b12873 ↗
66. 10.1016/j.apmt.2018.07.00610.1016/j.apmt.2018.07.006 ↗
67. 10.1016/j.bioactmat.2022.01.03610.1016/j.bioactmat.2022.01.036 ↗
68. 10.1002/adma.20200547710.1002/adma.202005477 ↗